Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Shareholders??? Deficit

v3.22.1
Consolidated Statements of Changes in Shareholders’ Deficit - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interest
Total
Balance at Dec. 31, 2019 $ 116,750 $ 37,266,328 $ (40,000,015)   $ (2,616,937)
Balance (in Shares) at Dec. 31, 2019 116,749,633        
Shares issued for conversion of accounts payable $ 151 5,907 6,058
Shares issued for conversion of accounts payable (in Shares) 151,456        
Shares issued for conversion of accrued compensation $ 751 28,102 28,853
Shares issued for conversion of accrued compensation (in Shares) 751,070        
Beneficial conversion charge for issuance of Series B preferred shares for accrued compensation recorded as stock-based compensation 1,048,143 1,048,143
Common shares issued for cash $ 37,390 783,610 821,000
Common shares issued for cash (in Shares) 37,390,314        
Common shares issued for conversion of debt, accrued interest and fees $ 37,172 153,857 191,029
Common shares issued for conversion of debt, accrued interest and fees (in Shares) 37,171,800        
Common shares issued for services $ 20,000 129,475 149,475
Common shares issued for services (in Shares) 20,000,000        
Extinguishment loss related to conversion of debt 297,919 297,919
Common shares issued for conversion of Series A preferred shares and dividends $ 16,133 199,291 215,424
Common shares issued for conversion of Series A preferred shares and dividends (in Shares) 16,132,701        
Issuance of warrants in connection with convertible debt 14,498 14,498
Reclassification of put premium to equity upon conversion of Series A preferred 49,543 49,543
Accretion of stock-based compensation 446,064 446,064
Accretion of stock-based professional fees 15,000 15,000
Accretion of stock option expense 609,662 609,662
Preferred stock dividends and deemed dividend 1,525,873 (1,534,381) (8,508)
Net loss (4,434,443) (4,434,443)
Balance at Dec. 31, 2020 $ 228,347 42,573,272 (45,968,839) (3,167,220)
Balance (in Shares) at Dec. 31, 2020 228,346,974        
Common shares issued for accounts payable $ 3,801 114,037 117,838
Common shares issued for accounts payable (in Shares) 3,801,224        
Common shares issued for acquisition $ 28,021 666,900 694,921
Common shares issued for acquisition (in Shares) 28,021,016        
Common shares issued for professional fees $ 13,250 540,950 554,200
Common shares issued for professional fees (in Shares) 13,250,000        
Common shares issued for compensation $ 4,677 19,736 24,413
Common shares issued for compensation (in Shares) 4,676,500        
Common shares issued for accrued compensation $ 945 54,796 55,741
Common shares issued for accrued compensation (in Shares) 944,767        
Common shares issued for cashless warrant exercise $ 1,008 (1,008)  
Common shares issued for cashless warrant exercise (in Shares) 1,008,000        
Common shares issued for conversion of Series C preferred stock $ 1,500 10,500 12,000
Common shares issued for conversion of Series C preferred stock (in Shares) 1,500,000        
Common stock issued in connection with convertible debt $ 668 13,396     14,064
Common stock issued in connection with convertible debt (in Shares) 668,151        
Preferred stock dividends and deemed dividend 4,354,761 (4,401,907) (47,146)
Initial noncontrolling in acquired business 173,730 173,730
Beneficial conversion feature connection with convertible debt 318,794 318,794
Beneficial conversion charge for issuance of Series B preferred shares for accrued compensation recorded as stock-based compensation 3,778,810 3,778,810
Issuance of warrants in connection with convertible debt 347,142 347,142
Accretion of stock-based compensation   267,530 267,530
Accretion of stock-based professional fees 5,000 5,000
Net loss (7,144,383) 15,525 (7,128,858)
Balance at Dec. 31, 2021 $ 282,217 $ 53,064,616 $ (57,515,129) $ 189,255 $ (3,979,041)
Balance (in Shares) at Dec. 31, 2021 282,216,632